Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings
- PMID: 30556824
- PMCID: PMC6439662
- DOI: 10.1001/jamainternmed.2018.5565
Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings
Abstract
Importance: Guidelines recommend a 10-year rescreening interval after a colonoscopy with normal findings (negative colonoscopy results), but evidence supporting this recommendation is limited.
Objective: To examine the long-term risks of colorectal cancer and colorectal cancer deaths after a negative colonoscopy result, in comparison with individuals unscreened, in a large, community-based setting.
Design, setting, and participants: A retrospective cohort study was conducted in an integrated health care delivery organization serving more than 4 million members across Northern California. A total of 1 251 318 average-risk screening-eligible patients (age 50-75 years) between January 1, 1998, and December 31, 2015, were included. The study was concluded on December 31, 2016.
Exposures: Screening was examined as a time-varying exposure; all participants contributed person-time unscreened until they were either screened or censored. If the screening received was a negative colonoscopy result, the participants contributed person-time in the negative colonoscopy results group until they were censored.
Main outcomes and measures: Using Cox proportional hazards regression models, the hazard ratios (HRs) for colorectal cancer and related deaths were calculated according to time since negative colonoscopy result (or since cohort entry for those unscreened). Hazard ratios were adjusted for age, sex, race/ethnicity, Charlson comorbidity score, and body mass index.
Results: Of the 1 251 318 patients, 613 692 were men (49.0%); mean age was 55.6 (7.0) years. Compared with the unscreened participants, those with a negative colonoscopy result had a reduced risk of colorectal cancer and related deaths throughout the more than 12-year follow-up period, and although reductions in risk were attenuated with increasing years of follow-up, there was a 46% lower risk of colorectal cancer (hazard ratio, 0.54; 95% CI, 0.31-0.94) and 88% lower risk of related deaths (hazard ratio, 0.12; 95% CI, 0.02-0.82) at the current guideline-recommended 10-year rescreening interval.
Conclusions and relevance: A negative colonoscopy result in average-risk patients was associated with a lower risk of colorectal cancer and related deaths for more than 12 years after examination, compared with unscreened patients. Our study findings may be able to inform guidelines for rescreening after a negative colonoscopy result and future studies to evaluate the costs and benefits of earlier vs later rescreening intervals.
Conflict of interest statement
Figures
Similar articles
-
Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995. JAMA Netw Open. 2019. PMID: 31860105 Free PMC article.
-
Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort study.Lancet Gastroenterol Hepatol. 2024 Jul;9(7):601-608. doi: 10.1016/S2468-1253(24)00084-0. Epub 2024 May 16. Lancet Gastroenterol Hepatol. 2024. PMID: 38761808
-
Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer.JAMA. 2022 Jun 7;327(21):2114-2122. doi: 10.1001/jama.2022.6644. JAMA. 2022. PMID: 35670788 Free PMC article.
-
Colorectal Cancer Screening: An Updated Decision Analysis for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 May. Report No.: 20-05271-EF-2. PMID: 34097370 Free Books & Documents. Review.
-
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. Report No.: 17-05231-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug. Report No.: 17-05231-EF-1. PMID: 30256575 Free Books & Documents. Review.
Cited by
-
Post-polypectomy surveillance: follow-up recommendations from the Alberta Colorectal Cancer Screening Program.J Can Assoc Gastroenterol. 2024 Mar 19;7(4):319-328. doi: 10.1093/jcag/gwae007. eCollection 2024 Aug. J Can Assoc Gastroenterol. 2024. PMID: 39139219 Free PMC article.
-
Adherence to Recommendations for Repeat Surveillance After Publication of New Postpolypectomy Guidelines.Gastro Hep Adv. 2022 Jul 31;2(1):132-143. doi: 10.1016/j.gastha.2022.07.014. eCollection 2023. Gastro Hep Adv. 2022. PMID: 39130145 Free PMC article.
-
Colorectal cancer screening-what does the recent NordICC trial mean for the U.S. population?Transl Gastroenterol Hepatol. 2023 Aug 30;8:40. doi: 10.21037/tgh-23-20. eCollection 2023. Transl Gastroenterol Hepatol. 2023. PMID: 38021363 Free PMC article. Review.
-
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4. Endoscopy. 2023. PMID: 37793423 Free PMC article.
-
Low Incidence of Colorectal Advanced Neoplasia During Surveillance in Individuals with a Family History of Colorectal Cancer.Dig Dis Sci. 2023 Nov;68(11):4243-4251. doi: 10.1007/s10620-023-08053-6. Epub 2023 Sep 8. Dig Dis Sci. 2023. PMID: 37682374 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
